bharat biotech international limited

Bharat Biotech’s intranasal COVID-19 vaccine to cost ₹800 for private markets

by
Bharat Biotech’s intranasal COVID-19 vaccine to cost ₹800 for private markets

Image for representational purposes only. | Photo Credit: The Hindu Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at ₹800 (excluding GST) for private markets and ₹325 (excluding GST) for government supplies. A press release from the vaccine maker said the jab … Read more

Covaxin interim data shows it is 77.8% effective against symptomatic Covid, gives 65.2% protection from Delta variant: The Lancet

by
Covaxin interim data shows it is 77.8% effective against symptomatic Covid, gives 65.2% protection from Delta variant: The Lancet

World Health Organization approved Covaxin for use among people aged 18 years and above Bharat Biotech’s Covaxin demonstrates 77.8 per cent efficacy against symptomatic Covid-19, peer-reviewed general medical journal The Lancet confirmed. As per phase-three clinical trials data, Covaxin is also the only Covid-19 vaccine that has demonstrated efficacy data against delta variant at 65.2 … Read more